Загрузка...
Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma
This study was conducted to evaluate the toxicity and efficacy of pemetrexed plus dendritic cells (DCs) when administered as third-line treatment for metastatic esophageal squamous cell carcinoma (ESCC). All patients in the study group had previously failed first-line treatment with 5-fluorouracil a...
Сохранить в:
| Опубликовано в: : | Onco Targets Ther |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4935028/ https://ncbi.nlm.nih.gov/pubmed/27418834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S107319 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|